Abstract
Staphylococcus aureus is a leading human pathogen that causes a large variety of diseases. In vitro studies have shown that S. aureus secretes several small proteins that block specific elements of the host innate immune system, but their role in bacterial pathogenicity is unknown. For instance, the extracellular complement-binding protein (Ecb) impairs complement activation by binding to the C3d domain of C3. Its homolog, the extracellular fibrinogen-binding protein (Efb), is known to block both complement activation and neutrophil adhesion to fibrinogen. Here, we show that targeted inactivation of the genes encoding Ecb and Efb strongly attenuates S. aureus virulence in a murine infection model: mice experienced significantly higher mortality rates upon intravenous infection with wild-type bacteria (79%) than with an isogenic ΔEcbΔEfb mutant (21%). In addition, Ecb and Efb are both required for staphylococcal persistence in host tissues and abscess formation in the kidneys (27% for wild-type vs. 7% for the ΔEcbΔEfb mutant). During staphylococcal pneumonia, Ecb and Efb together promote bacterial survival in the lungs (p = 0.03) and block neutrophil influx into the lungs. Thus, Ecb and Efb are essential to S. aureus virulence in vivo and could be attractive targets in future vaccine development efforts.
Journal Section:
Editor's choice
References
1.
Klevens RM, Morrison MA, Nadle J, et al: Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763–1771.
[PubMed]
2.
McCaig LF, McDonald LC, Mandal S, Jernigan DB: Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis 2006;12:1715–1723.
3.
Schaffer AC, Lee JC: Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents 2008;32(suppl 1):71–78.
4.
Chavakis T, Preissner KT, Herrmann M: The anti-inflammatory activities of Staphylococcus aureus. Trends Immunol 2007;28:408–418.
[PubMed]
5.
Patti JM, Allen BL, McGavin MJ, Höök M: MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 1994;48:585–617.
[PubMed]
6.
Serruto D, Rappuoli R, Scarselli M, Gros P, van Strijp JAG: Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat Rev Micro 2010;8:393–399.
7.
Nathan C: Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006;6:173–182.
[PubMed]
8.
Ricklin D, Hajishengallis G, Yang K, Lambris JD: Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010;11:785–797.
[PubMed]
9.
Forsyth CB, Solovjov DA, Ugarova TP, Plow EF: Integrin alpha(M)beta-mediated cell migration to fibrinogen and its recognition peptides. J Exp Med 2001;193:1123–1133.
10.
Cruz-Topete D, Iwaki T, Ploplis VA, Castellino FJ: Delayed inflammatory responses to endotoxin in fibrinogen-deficient mice. J Pathol 2006;210:325–333.
11.
Drew AF, Liu H, Davidson JM, Daugherty CC, Degen JL: Wound-healing defects in mice lacking fibrinogen. Blood 2006;97:3691–3698.
12.
Park K-H, Kurokawa K, Zheng L, et al: Human serum mannose-binding lectin senses wall teichoic acid glycopolymer of Staphylococcus aureus, which is restricted in infancy. J Biol Chem 2010;285:27167–27175.
13.
Takahashi K, Shi L, Gowda LD, Ezekowitz RAB: Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection. Infect Immun 2005;73:8188–8193.
14.
von Köckritz-Blickwede M, Konrad S, Foster S, Gessner JE, Medina E: Protective role of complement C5a in an experimental model of Staphylococcus aureus bacteremia. J Innate Immun 2009;2:87–92.
15.
Hammel M, Sfyroera G, Pyrpassopoulos S, et al: Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. J Biol Chem 2007;282:30051–30061.
16.
Jongerius I, Köhl J, Pandey MK, et al: Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 2007;204:2461–2471.
17.
Ko YP, Liang X, Smith CW, Degen JL, Höök M: Binding of Efb from Staphylococcus aureus to fibrinogen blocks neutrophil adherence. J Biol Chem 2011;286:9865–74.
18.
Palma M, Shannon O, Quezada HC, Berg A, Flock JI: Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the alpha-chain. J Biol Chem 2001;276:31691–31697.
19.
Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P: Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol 1988;170:4365–4372.
20.
Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K: Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol 2008;190:300–310.
21.
Kemp EH, Sammons RL, Moir A, Sun D, Setlow P: Analysis of transcriptional control of the gerD spore germination gene of Bacillus subtilis 168. J Bacteriol 1991;173:4646–4652.
22.
Grkovic S, Brown MH, Hardie KM, Firth N, Skurray RA: Stable low-copy-number Staphylococcus aureus shuttle vectors. Microbiology 2003;149:785–794.
23.
Augustin J, Rosenstein R, Wieland B, Schneider U, Schnell N, Engelke G, et al: Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur J Biochem 1992;204:1149–1154.
[PubMed]
24.
Horsburgh MJ, Clements MO, Crossley H, Ingham E, Foster SJ: PerR controls oxidative stress resistance and iron storage proteins and is required for virulence in Staphylococcus aureus. Infect Immun 2001;69:3744–3754.
[PubMed]
25.
Kenny JG, Ward D, Josefsson E, et al: The Staphylococcus aureus response to unsaturated long-chain-free fatty acids: survival mechanisms and virulence implications. PLoS One 2009;4:e4344.
26.
Laarman AJ, Ruyken M, Malone CL, et al: Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J Immunol 2011;186:6445–6453.
27.
Kew RR, Peng T, DiMartino SJ, Madhavan D, Weinman SJ, Cheng D, Prossnitz ER: Undifferentiated U937 cells transfected with chemoattractant receptors: a model system to investigate chemotactic mechanisms and receptor structure/function relationships. J Leukoc Biol 1997;61:329–337.
28.
Bubeck Wardenburg J, Patel RJ, Schneewind O: Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 2007;75:1040–1044.
[PubMed]
29.
Cheng AG, Kim HK, Burts ML, et al: Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 2009;23:3393–3404.
30.
Potempa J, Pike RN: Corruption of innate immunity by bacterial proteases. J Innate Immun 2009;1:70–87.
31.
McCarthy AJ, Lindsay JA: Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions. BMC Microbiol 2010;10:173.
32.
Burian M, Wolz C, Goerke C: Regulatory adaptation of Staphylococcus aureus during nasal colonization of humans. PLoS One 2010;5:e10040.
33.
Verkaik NJ, Lebon A, de Vogel CP, et al: Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin Microbiol Infect 2010;16:1312–1317.
34.
Shannon O, Uekotter A, Flock JI: The neutralizing effects of hyperimmune antibodies against extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus. Scand J Immunol 2006;63:184–90.
35.
Robertson CM, Perrone EE, McConnell KW, et al: Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance. J Surg Res 2008;150:278–285.
36.
van den Berg JM, et al: Chronic granulomatous disease: the European experience. PLoS One 2009;4:e5234.
37.
Cerquetti MC, Sordelli DO, Ortegon RA, Bellanti JA: Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement. Infect Immun 1983;41:1071–1076.
[PubMed]
38.
Flick MJ, Du X, Witte DP, et al: Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 2004;113:1596–606.
39.
Zarbock A, Polanowska-Grabowska RK, Ley K: Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 2006;21:99–111.
40.
Cheng AG, McAdow M, Kim HK, et al: Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog 2010;6:e1001036.
41.
Kim HK, Cheng AG, Kim HY, Missiakas DM, Schneewind O: Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med 2010;207:1863–1870.
© 2012 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2012
You do not currently have access to this content.
